PMC:7047037 / 7858-8176 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"92","span":{"begin":281,"end":309},"obj":"Species"},{"id":"93","span":{"begin":311,"end":314},"obj":"Species"}],"attributes":[{"id":"A92","pred":"tao:has_database_id","subj":"92","obj":"Tax:12721"},{"id":"A93","pred":"tao:has_database_id","subj":"93","obj":"Tax:12721"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" for neglected diseases\nGlobal funding for research and product development for neglected diseases reached a record high of $4.0 billion in 2018 according to the 2019 G-FINDER survey, which reports on global investment in research and development for neglected diseases, including human immunodeficiency virus (HIV), t"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":311,"end":314},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma278683"}],"text":" for neglected diseases\nGlobal funding for research and product development for neglected diseases reached a record high of $4.0 billion in 2018 according to the 2019 G-FINDER survey, which reports on global investment in research and development for neglected diseases, including human immunodeficiency virus (HIV), t"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T18","span":{"begin":287,"end":303},"obj":"Disease"}],"attributes":[{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0021094"}],"text":" for neglected diseases\nGlobal funding for research and product development for neglected diseases reached a record high of $4.0 billion in 2018 according to the 2019 G-FINDER survey, which reports on global investment in research and development for neglected diseases, including human immunodeficiency virus (HIV), t"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T59","span":{"begin":107,"end":108},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T60","span":{"begin":140,"end":144},"obj":"http://purl.obolibrary.org/obo/CLO_0001185"},{"id":"T61","span":{"begin":281,"end":286},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T62","span":{"begin":304,"end":309},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":" for neglected diseases\nGlobal funding for research and product development for neglected diseases reached a record high of $4.0 billion in 2018 according to the 2019 G-FINDER survey, which reports on global investment in research and development for neglected diseases, including human immunodeficiency virus (HIV), t"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T9","span":{"begin":287,"end":303},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002721"}],"text":" for neglected diseases\nGlobal funding for research and product development for neglected diseases reached a record high of $4.0 billion in 2018 according to the 2019 G-FINDER survey, which reports on global investment in research and development for neglected diseases, including human immunodeficiency virus (HIV), t"}